A Letter from Dr. Schefler
Hearing that your baby has cancer is one of the scariest moments in a parent’s life.
Retinoblastoma is a rare disease, with only 250 to 350 new patients diagnosed per year in the United States. We at Retina Consultants of Houston along with Children’s Memorial Hermann Hospital are one of the only centers in the nation that specialize in the care of children with this disease. We take care of patients with this problem every day and are engaged in cutting-edge research to try to help find better treatments and a cure for this rare cancer. Our doctors attend national and international meetings every year to present their research findings with other experts around the world. We pride ourselves on outstanding care for children and for their families. You will find that our team is accessible and kind, and treats your child as if he/she were our own.
We are honored to take care of your child.
Testimonial: A Child's Journey with Retinoblastoma
Retinoblastoma is the most common eye cancer in children. However, among the general population, the disease is actually very rare. In fact, it occurs in only 250 to 350 new children in the U.S. per year; an average of one in every 15,000 to 20,000 births. Worldwide, the disease affects about 8,000 children per year (0.006 percent of all births). We know from years of working with retinoblastoma families that receiving this diagnosis can be terribly distressing. The good news is that it is highly curable in places like the U.S., where modern treatment is available. Although the untreated disease continues to claim many lives in developing areas of the world, retinoblastoma has the highest survival rate among all pediatric cancers in the United States.
With all of the advances in treatment options over the past few decades, up to 98 percent of patients diagnosed with retinoblastoma in the U.S. survive the initial cancer. In addition, over 90 percent of those retinoblastoma patients will be able to retain good vision in at least one and possibly both eyes.